Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PROVE-IT proves that lower is better: a contrary view.

Steven A Grover1

  • 1Centre for the Analysis of Cost-Effective Care and the Division of General Internal Medicine, The Montreal General Hospital, Montreal, Quebec. steven.grover@mcgill.ca

The Canadian Journal of Cardiology
|February 25, 2006
PubMed
Summary

Lowering low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) together improves cardiovascular outcomes more than lowering LDL alone. Statins show varied effects on CRP, influencing overall cardiovascular benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outpatient Therapies for COVID-19: How Do We Choose?

Open forum infectious diseases·2022
Same author

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.

The Canadian journal of cardiology·2021
Same author

Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use.

The Canadian journal of cardiology·2021
Same author

The Sustainability of a Workplace Wellness Program That Incorporates Gamification Principles: Participant Engagement and Health Benefits After 2 Years.

American journal of health promotion : AJHP·2019
Same author

Cardiovascular Risk Assessment and Follow-Up of Women After Hypertensive Disorders of Pregnancy:A Prospective Cohort Study.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2019
Same author

Evaluation of the cost-effectiveness of evolocumab in the FOURIER study: a Canadian analysis.

CMAJ open·2018

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) are established independent risk factors for cardiovascular events.
  • Statin therapy, primarily for lipid modification, exhibits pleiotropic effects, including CRP reduction.

Discussion:

  • Conflicting results from recent clinical trials on intensive LDL lowering highlight the importance of pleiotropic effects.
  • Specific statins' differential impact on CRP concentrations may significantly influence observed therapeutic benefits.

Key Insights:

  • Lowering both LDL cholesterol and CRP offers superior cardiovascular protection compared to LDL reduction alone.
  • The pleiotropic effects of statins, particularly on CRP, are crucial determinants of their efficacy in preventing cardiovascular events.

Related Experiment Videos

Outlook:

  • Future cardiovascular event prevention strategies should consider targeting both LDL cholesterol and CRP.
  • Further research into statin-specific pleiotropic mechanisms could optimize cardiovascular risk management.